Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17 GBX | -2.86% | -6.85% | -75.71% |
Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
Apr. 25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
Sales 2023 | 832K 1.04M | Sales 2024 * | 533K 668K | Capitalization | 16.2M 20.3M |
---|---|---|---|---|---|
Net income 2023 | -5M -6.26M | Net income 2024 * | -5M -6.26M | EV / Sales 2023 | 72.5 x |
Net cash position 2023 | 6.38M 8M | Net cash position 2024 * | 2.25M 2.82M | EV / Sales 2024 * | 26.2 x |
P/E ratio 2023 |
-11.3
x | P/E ratio 2024 * |
-2.87
x | Employees | 24 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.35% |
Latest transcript on Destiny Pharma plc
1 day | -2.86% | ||
1 week | -6.85% | ||
Current month | -4.23% | ||
1 month | -35.85% | ||
3 months | -56.96% | ||
6 months | -75.54% | ||
Current year | -75.71% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 23-08-31 | |
William Love
FOU | Founder | 62 | 96-03-03 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 11-08-31 |
William Love
FOU | Founder | 62 | 96-03-03 |
Nigel Brooksby
BRD | Director/Board Member | - | 22-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 17 | -2.86% | 150 730 |
24-05-09 | 17.5 | +2.94% | 7,648 |
24-05-08 | 17 | -5.56% | 157,421 |
24-05-07 | 18 | -1.37% | 225,759 |
24-05-03 | 18.25 | 0.00% | 232,775 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.71% | 20.87M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- DEST Stock